Organizer
Waters Corporation
Waters Corporation
Waters Corporation, the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years.
Tags
HPLC
PrepLC
LinkedIn Logo

A Focus on PCR Diagnostic Probes: Oligonucleotide LC Analysis and Purification

RECORD | Already taken place We, 31.3.2021
We’ll discuss strategies for lab scale and semi-preparative purification of diagnostic probes through illustrated examples. In addition, we’ll review PREMIER solutions.
Go to the webinar
Waters Corporation: A Focus on PCR Diagnostic Probes: Oligonucleotide LC Analysis and Purification
Waters Corporation: A Focus on PCR Diagnostic Probes: Oligonucleotide LC Analysis and Purification

Liquid chromatography (LC) is an indispensable method for quality control, characterization, and purification of the nucleic acids. Therapeutic oligonucleotides, mRNA vaccines, and diagnostic oligonucleotide PCR probes are typically analyzed by an ion-pairing reversed-phase LC (IP RP LC) method. Each of these application areas are readily applicable to Covid-19 research.

In this presentation we’ll discuss:

  • Principles of IP RP LC
  • Impact of ion-pairing system choice on oligonucleotide separation selectivity
  • Purification applications for labeled oligonucleotide probes used in PCR-based diagnostics
  • Applications of IP RP LC for LC MS for characterization of nucleic acids

In addition, we’ll review PREMIER solutions for the acidic nature of nucleic acids that can cause undesirable adsorption on metallic surfaces in LC systems and columns.

Presenter: Martin Gilar, Ph.D. (Scientific Fellow, Separations Research, Waters Corporation)

Dr. Martin Gilar is a Scientific Fellow in Separations Research group at Waters Corporation. He has more than 30 years of experience in the separation sciences, namely chromatography, electrophoresis, and mass spectrometry. His research interest is analysis of biopolymers such as oligonucleotides, peptides, glycans and proteins. He has published over 70 peer reviewed papers.

Dr. Gilar’s received his Ph.D. in analytical chemistry from Institute of Chemical Technology in Prague (1996). He spent postdoc years in Hybridon Inc. (1996-1998) and Northeastern University in Boston (1998) developing separation methods for antisense oligonucleotides and fraction collector for DNA molecules. Since 1998 he works at Waters Corp. in Milford, Massachusetts.

Waters Corporation
LinkedIn Logo
 

Related content

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Metabolomics

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Environmental

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Environmental

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/HRMS, Particle characterization, LC/IT
Manufacturer
Waters
Industries
Lipidomics

Out-of-the-box workflow for PFAS quantitation using a fullscan high-resolution approach with the Orbitrap Exploris EFOX Mass Detector

Applications
| 2025 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Environmental
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike